Archer Daniels Midland Company (ADM) Barclays 18th Annual Global Consumer Staples Conference 2025 summary

Financial performance and operational highlights

• Achieved $0.93 EPS in Q2, surpassing market expectations, with Ag Services & Oilseeds and Carbohydrate Solutions performing steadily and Nutrition showing sequential improvements.

• Nutrition business benefited from the restart of a key protein plant, enhancing future supply and operational efficiency.

• Portfolio simplification included exiting non-strategic units and consolidating specialty protein capacity.

• Cost reduction efforts are on track, targeting $500–$750 million over 3–5 years, with $200–$300 million expected this year.

• Dividend increased for the 375th consecutive quarter, reflecting a balanced capital allocation approach.

Market outlook and regulatory environment

• Regulatory clarity around biofuels and decarbonization is improving, supporting stronger margins in Carbohydrate Solutions.

• Q4 is expected to be stronger due to improved crush margins, full harvest season, and the impact of the recommissioned Nutrition plant.

• Large crop yields in the U.S., Brazil, and Argentina are expected to support high plant utilization.

• Ethanol margins are stable, with strong export markets and favorable weather supporting demand.

Nutrition business strategy and investments

• Decatur protein facility is fully operational, driving immediate cost efficiencies and supporting margin recovery.

• Focus on regaining lost market share and optimizing the global protein network by consolidating production in high-quality, efficient facilities.

• Investments in flavors, probiotics, and specialty ingredients are prioritized, with ongoing R&D and capacity expansion in health and wellness.

• Animal Nutrition pivots toward specialty feed for higher growth and margins, with light capacity investments.

• Capital allocation in Nutrition is returns-focused, with investments evaluated project by project.